A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

PHASE2CompletedINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

May 14, 2019

Study Completion Date

May 14, 2019

Conditions
Neovascular Age-related Macular Degeneration
Interventions
BIOLOGICAL

OPT-302

Intravitreal injection

BIOLOGICAL

ranibizumab

Intravitreal injection

OTHER

sham intravitreal injection

Sham (mock) intravitreal injection

Trial Locations (108)

1006

Opthea Investigational Site, Riga

1009

Opthea Investigational Site, Riga

1062

Opthea Investigational Site, Budapest

1133

Opthea Investigational Site, Budapest

6720

Opthea Investigational Site, Szeged

10034

Opthea Investigational Site, Prague

11563

Opthea Investigational Site, Lynbrook

12808

Opthea Investigational Site, Prague

13224

Opthea Investigational Site, Syracuse

14620

Opthea Investigational Site, Rochester

17011

Opthea Investigational Site, Camp Hill

18704

Opthea Investigational Site, Kingston

19107

Opthea Investigational Site, Philadelphia

20079

Opthea Investigationa Site, Lublin

20157

Opthea Investigational Site, Milan

21079

Opthea Investigational Site, Dijon

21204

Opthea Investigational Site, Baltimore

22031

Opthea Investigational Site, Fairfax

23462

Opthea Investigational Site, Virginia Beach

28210

Opthea Investigational Site, Charlotte

28803

Opthea Investigational Site, Asheville

29169

Opthea Investigational Site, West Columbia

29456

Opthea Investigational Site, Ladson

30909

Opthea Investigational Site, Augusta

31048

Opthea Investigational Site, Haifa

32308

Opthea Investigational Site, Tallahassee

32503

Opthea Investigational Site, Pensacola

32901

Opthea Investigational Site, Melbourne

33426

Opthea Investigational Site, Boynton Beach

33703

Opthea Investigational Site, St. Petersburg

33880

Opthea Investigational Site, Winter Haven

33907

Opthea Investigational Site, Fort Myers

33912

Opthea Investigational Site, Fort Myers

40138

Opthea Investigational Site, Bologna

42001

Opthea Investigational Site, Paducah

43212

Opthea Investigational Site, Columbus

44195

Opthea Investigational Site, Cleveland

49546

Opthea Investigational Site, Grand Rapids

50005

Opthea Investigational Site, Hradec Králové

50134

Opthea Investigational Site, Florence

66204

Opthea Investigational Site, Shawnee Mission

67090

Opthea Investigational Site, Strasbourg

67214

Opthea Investigational Site, Wichita

69130

Opthea Investigational Site, Écully

75010

Opthea Investigational Site, Paris

75019

Opthea Investigational Site, Paris

76087

Opthea Investigational Site, Willow Park

77030

Opthea Investigational Site, Houston

77384

Opthea Investigational Site, The Woodlands

78240

Opthea Investigational Site, San Antonio

78705

Opthea Investigational Site, Austin

79606

Opthea Investigational Site, Abilene

80401

Opthea Investigational Site, Golden

80909

Opthea Investigational Site, Colorado Springs

85014

Opthea Investigational Site, Phoenix

85020

Opthea Investigational Site, Phoenix

87109

Opthea Investigational Site, Albuquerque

89144

Opthea Investigational Site, Las Vegas

89502

Opthea Investigational Site, Reno

90211

Opthea Investigational Site, Beverly Hills

91031

Opthea Investigational Site, Jerusalem

91436

Opthea Investigational Site, Encino

92260

Opthea Investigational Site, Palm Desert

92374

Opthea Investigational Site, Redlands

92705

Opthea Investigational Site, Santa Ana

93103

Opthea Investigational Site, Santa Barbara

93454

Opthea Investigational Site, Santa Maria

94010

Opthea Investigational Site, Créteil

94143

Opthea Investigational Site, San Diego

95819

Opthea Study Site, Sacramento

95841

Opthea Investigational Site, Sacramento

97239

Opthea Investigational Site, Portland

98383

Opthea Investigational Site, Silverdale

08820

Opthea Investigational Site, Edison

07666

Opthea Investigational Site, Teaneck

Unknown

Opthea Investigational Site, Budapest

Opthea Investigational Site, Nyíregyháza

Opthea Investigational Site, Haifa

Opthea Investigational Site, Jerusalem

Opthea Investigational Site, Kfar Saba

Opthea Investigational Site, Petah Tikva

Opthea Investigational Site, Rehovot

Opthea Investigational Site, Tel Aviv

Opthea Investigational Site, Milan

Opthea Investigational Site, Jelgava

Opthea Investigational Site, Riga

Opthea Investigational Site, Bydgoszcz

Opthea Investigational Site, Gdansk

Opthea Investigational Site, Katowice

Opthea Investigational Site, Krakow

Opthea Investigational Site, Lublin

Opthea Investigational Site, Wroclaw

Opthea Investigational Site, Barcelona

Opthea Investigational Site, Bilbao

Opthea Investigational Site, Madrid

Opthea Investigational Site, Oviedo

Opthea Investigational Site, Pamplona

Opthea Investigational Site, Santiago de Compostela

Opthea Investigational Site, Valencia

Opthea Investigational Site, Valladolid

Opthea Investigational Site, Bristol

Opthea Investigational Site, Frimley

Opthea Investigational Site, Glasgow

Opthea Investigational Site, London

Opthea Investigational Site, Maidstone

Opthea Investigational Site, Sheffield

Opthea Investigational Site, Wolverhampton

00133

Opthea Investigational Site, Roma

All Listed Sponsors
lead

Opthea Limited

INDUSTRY

NCT03345082 - A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD | Biotech Hunter | Biotech Hunter